logo-large
  • Browse Categories

Publications by authors named "Clare Devlin"

Claim this Profile
M
Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib.
Tamara van Donge, Elena Guerini, Amaury O'Jeanson, Neil Parrott, Clare Devlin

CPT Pharmacometrics Syst Pharmacol· June 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions.
Ami V Desai, Aditi Bagchi, Amy E Armstrong, Cornelis M van Tilburg, Ellen M Basu, Clare E Devlin

Eur J Cancer· May 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Ami V Desai, Giles W Robinson, Karen Gauvain, Ellen M Basu, Margaret E Macy, Clare Devlin

Neuro Oncol· October 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.
Tanya Trippett, Helen Toledano, Quentin Campbell Hewson, Arnauld Verschuur, Anne-Marie Langevin, Clare Devlin

Target Oncol· May 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: